Answers are grounded in this paper and cite their sources.
BACKGROUND: Keratoacanthoma (KA) and cutaneous squamous cell carcinoma (cSCC) show substantial clinicopathological overlap. We compared their stromal T-cell infiltrates and tumoral progranulin (PRGN) expression. METHODS: This retrospective cross-sectional comparative study of diagnosis-selected cases included 30 KA and 32 cSCC lesions. Tissue microarrays were stained for CD4, CD8, FOXP3, and PRGN. RESULTS: Compared with KA, cSCC showed higher stromal CD4+ counts [median (IQR), 89.5 (62.2-125.3) vs. 47.2 (24.4-92.9); p = 0.009] and CD8+ counts [mean ± SD, 146.6 ± 77.9 vs. 98.0 ± 64.7; p = 0.010], whereas FOXP3+ counts did not differ significantly [median (IQR), 83.0 (56.3-115.3) vs. 51.6 (36.5-97.1); p = 0.076]. Overall PRGN positivity did not differ between the groups (p = 0.238), whereas the four-level intensity distribution shifted toward stronger staining in cSCC (p < 0.001). Each one-category increase in PRGN intensity was independently associated with cSCC (adjusted OR, 2.318; 95% CI 1.143-4.703; p = 0.020). In an exploratory analysis restricted to KA, moderate-to-strong PRGN expression was associated with higher FOXP3+ counts than weak expression (p = 0.007). CONCLUSIONS: cSCC showed higher unadjusted CD4+ and CD8+ counts, whereas only ordinal PRGN intensity remained associated with tumor type after adjustment. The modest sample and semiquantitative single-observer assessment warrant cautious interpretation and validation in independent cohorts.
No takes yet. Share an insight, caveat, or question.
Dede et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: